Related Experiment Video
Updated: Jul 11, 2026
04:36
An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
Published on: January 12, 2024
Homocysteine and diabetic retinopathy
Laima Brazionis1, Kevin Rowley, Catherine Itsiopoulos
1Department of Medicine, University of Melbourne, St. Vincent's Hospital, P.O. Box 2900, Fitzroy, Victoria 3065, Australia. laimab@medstv.unimelb.edu.au
Diabetes Care
|September 28, 2007
Summary
Elevated homocysteine levels are linked to diabetic retinopathy in type 2 diabetes patients. This study suggests homocysteine may be a novel risk factor for this common diabetes complication.
Area of Science:
- Endocrinology
- Ophthalmology
- Cardiovascular Research
Background:
- Homocysteine is an emerging risk factor for vaso-occlusive diseases.
- Previous studies on homocysteine and diabetic retinopathy have yielded inconsistent findings.
- Understanding homocysteine's role in diabetic retinopathy is crucial for diabetes management.
Purpose of the Study:
- To investigate the association between plasma total homocysteine concentration and diabetic retinopathy.
- To determine if homocysteine is an independent risk factor for diabetic retinopathy.
Main Methods:
- A cross-sectional study involving 168 individuals with type 2 diabetes.
- Photodocumented assessment of diabetic retinopathy status.
- Measurement of plasma total homocysteine using a fluorescence polarization immunoassay.
Main Results:
- Individuals with diabetic retinopathy had significantly higher mean plasma total homocysteine levels (11.5 mumol/l) compared to those without (9.6 mumol/l).
- The association between homocysteine and diabetic retinopathy was independent of renal dysfunction, diabetes duration, A1C, systolic blood pressure, age, sex, and red cell folate.
- An increased odds ratio (1.20) for diabetic retinopathy was observed with higher homocysteine concentrations.
Conclusions:
- Plasma total homocysteine concentration may serve as a valuable biomarker for diabetic retinopathy risk.
- Elevated homocysteine could be a novel risk factor for developing diabetic retinopathy in type 2 diabetes patients.
Related Concept Videos
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.